[HTML][HTML] Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities
L Pohl, J Friedhoff, C Jurcic, M Teroerde… - Frontiers in …, 2022 - frontiersin.org
Renal cell carcinoma (RCC) is among the most lethal urological malignancies once
metastatic. The introduction of immune checkpoint inhibitors has revolutionized the …
metastatic. The introduction of immune checkpoint inhibitors has revolutionized the …
[HTML][HTML] Renal cancer: From current evidence to future perspectives
C Fiori, F Porpiglia - Asian Journal of Urology, 2022 - ncbi.nlm.nih.gov
It has been a great honor to have the opportunity to serve as guest editors for this issue of
the Asian Journal of Urology (AJU) on renal cancer. Renal cell carcinoma (RCC) represents …
the Asian Journal of Urology (AJU) on renal cancer. Renal cell carcinoma (RCC) represents …
High Accuracy Discriminant Analysis of Preparation from 22 Commercial Antibodies Based on Uv Spectroscopy Combined with Chemometrics
A Dowek, M Annereau, L Denis, T Fleury… - Available at SSRN … - papers.ssrn.com
The demand for monoclonal antibodies (mAbs) in hospitals is continually rising due to the
advancement of targeted therapy or immunotherapy in cancer treatment. Typically, mAbs are …
advancement of targeted therapy or immunotherapy in cancer treatment. Typically, mAbs are …